Issue 4/1997
Content (11 Articles)
Multiple resistance modulators combined with carboplatin for resistant malignancies: A pilot study
David J. Stewart, Rakesh Goel, M. Christine Cripps, Susan Huan, Jonathan Yau, Shailendra Verma
Il-4r expression in AIDS-KS cells and response to rhIL-4 and IL-4 toxin (DAB389-IL-4)
Jie Cai, Tong Zheng, John Murphy, Cory A. Waters, George Y. Lin, Parkash S. Gill
An in vitro assessment of the antineoplastic potential of 2H-1,3-Oxazine-2,6(3H)-dione (3-oxauracil), a novel pyrimidine
Lawton Seal, Daniel Von Hoff, Richard Lawrence, Elzbieta Izbicka, Richard M. Jamison
Preclinical toxicity of a new oral anticancer drug, CI-994 (Acetyldinaline), in rats and dogs
Michael J. Graziano, GaryD. Pilcher, Kathleen M. Walsh, Olajide B. Kasalil, Louis Radulovic
Potent induction of human colon cancer cell uptake of chemotherapeutic drugs by N-myristoylated protein kinase C-α (PKC-α) pseudosubstrate peptides through a P-glycoprotein-independent mechanism
Philip J. Bergman, Karen R. Gravitt, Nancy E. Ward, Pedro Beltran, Krishna P. Gupta, Catherine A. O'Brian
An Eastern Cooperative Oncology Group phase I trial of all-trans-retinoic acid and interferon-alpha: E2Y92
Joan H. Schiller, Donna Neuberg, Dan Burns, Paul Ritch, Marilyn Larson, Mark Levitt, Janice Dutcher
Phase I study of high dose etoposide phosphatase with filgrastim (G-CSF) in the treatment of advanced refractory malignancies
John D. Hainsworth, Susan M. Utley, F. Anthony Greco
A Phase I trial of weekly gemcitabine administered as a prolonged infusion in patients with pancreatic cancer and other solid tumors
Randall Brand, Mary Capadano, Margaret Tempero
A Phase II study of 13-cis-retinoic acid in patients with advanced renal cell carcinoma
William J. Berg, Lawrence H. Schwartz, Alison Amsterdam, Madhu Mazumdar, Vaia Vlamis, Teresa Murray Law, David M. Nanus, Robert J. Motzer
Phase II evaluation of topotecan in patients with advanced colorectal cancer. A Southwest Oncology Group trial (SWOG 9241)
John S. Macdonald, Jacqueline K. Benedetti, Manuel Modiano, David S. Alberts
Phase II study of flutamide as second line chemotherapy in patients with advanced pancreatic cancer
Jivesh J. Sharma, Betty Razvillas, C.D. Stephens, Susan G. Hilsenbeck, Ashu Sharma, Mace L. Rothenberg